> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Arizona Approves First State Off-Label Info Bill
- URL: https://www.fdaweb.com/arizona-approves-first-state-off-label-info-bill/
- Published: 2017-03-29T12:00:00.000Z
- Updated: 2026-09-14T22:14:43.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5138325

The Arizona legislature has approved the Free Speech in Medicine Act that authorizes drug and medical device companies to communicate truthful off-label treatment information to medical professionals. The [bill](http://www.goldwaterinstitute.org/en/work/topics/healthcare/related-reforms-2/arizona-becomes-first-state-to-allow-pharmaceutica/?ref=fdaweb.com) was supported by the Goldwater Institute, which also has promoted state and federal “right-to-try” legislation.

The institute reports that the legislation passed in both the House and Senate with unanimous, bipartisan support and was signed by Gov. **Doug Ducey**.

“Curbing the exchange of information about off-label treatments by those with the most knowledge about the drug’s uses, risks, and side effects not only prevents patients from receiving the best possible care \[but\] it violates the constitutional right to free speech,” said Goldwater Institute executive vice president **Christina Sandefur**, who wrote model language upon which the Arizona bill is based. The bill restricts legal off-label communication to exchanges between companies and licensed healthcare professionals and does not permit companies to advertise off-label uses directly to the public.